A small molecule inhibitor of Bcl-2, HA14-1, also inhibits ceramide glucosyltransferase.
Satomi Niino, Yutaka Nakamura, Yoshio Hirabayashi, Michiyo Nagano-Ito, Shinichi Ichikawa
Index: Biochem. Biophys. Res. Commun. 433(2) , 170-4, (2013)
Full Text: HTML
Abstract
HA14-1 is a Bcl-2 inhibitor that is widely used for studies of apoptosis. In the course of searching for a ceramide glucosyltransferase inhibitor that catalyzes the first glycosylation step of glycosphingolipid synthesis, we unexpectedly found that HA-14-1 also has the ability to inhibit ceramide glucosyltransferase. The IC50 value of HA14-1 against ceramide glucosyltransferase is 4.5μM, which is lower than that reported for Bcl-2 in vitro. Kinetic analyses revealed that HA14-1 is a competitive and mixed-type inhibitor with respect to C6-NBD-ceramide and UDP-glucose, respectively.Copyright © 2013 Elsevier Inc. All rights reserved.
Related Compounds
Related Articles:
2013-09-01
[Biochim. Biophys. Acta 1828(9) , 2152-63, (2013)]
2013-04-12
[J. Chromatogr. A. 1285 , 159-64, (2013)]
2013-01-01
[J. Cosmet. Sci. 64(5) , 381-9, (2013)]
2012-01-01
[J. Cosmet. Sci. 63(3) , 205-12, (2012)]
2015-01-01
[Acta Chim. Slov. 62 , 411-9, (2015)]